Silica Nanorattle–Doxorubicin-Anchored Mesenchymal Stem Cells for Tumor-Tropic Therapy

Author:

Li Linlin1,Guan Yunqian2,Liu Huiyu1,Hao Nanjing13,Liu Tianlong1,Meng Xianwei1,Fu Changhui1,Li Yanzhen4,Qu Qiulian5,Zhang Yingge5,Ji Shangyi4,Chen Ling2,Chen Dong6,Tang Fangqiong1

Affiliation:

1. Laboratory of Controllable Preparation and Application of Nanomaterials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, People’s Republic of China

2. Cell Therapy Center, Beijing Institute of Geriatrics, Xuanwu Hospital, Capital Medical University, Beijing 100053, People’s Republic of China

3. Graduate School of the Chinese Academy of Sciences, Beijing 100049, People’s Republic of China

4. Department of Pathology, Sun Yat-Sen Cardiovascular Hospital, Shenzhen 518020, People’s Republic of China

5. Institute of Pharmacology and Toxicology and Key Laboratory of Nanopharmacology and Nanotoxicology, Beijing Academy of Medical Sciences, Beijing 100850, People’s Republic of China

6. Beijing Creative Nanophase Hi-Tech Co., Ltd. China, Beijing 100086, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3